Loading insider details...
Beta
Latest Form 4 (Jun 30, 2026): Grant/Award of 155,000 IKT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 155,000 | n/a |
| Jul 2, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 108,176 | n/a |
| Feb 20, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 56,600 | n/a |
| Oct 23, 2024 | Inhibikase Therapeutics, Inc. (IKT) | Purchase | 145,000 | $198.7K |
| Feb 27, 2024 | RayzeBio, Inc. (RYZB) | Disposition to Issuer | 78,433 | $4.90M |